Avenue Therapeutics Inc (ATXI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,221 | -1,529 | -1,858 | -11,696 | -10,137 |
| Accounts receivable | N/A | -800 | N/A | N/A | N/A |
| Other Working Capital | 682 | -228 | 447 | 179 | 373 |
| Other Operating Activity | 560 | 1,195 | 225 | 2,491 | 1,502 |
| Operating Cash Flow | $-979 | $-1,362 | $-1,186 | $-9,026 | $-8,262 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2,094 | 2,094 | 2,094 | 11,044 | 10,283 |
| Other Financing Activity | 0 | 0 | 0 | -1,207 | -1,207 |
| Financing Cash Flow | $2,094 | $2,094 | $2,094 | $9,837 | $9,076 |
| Beginning Cash Position | 2,594 | 2,594 | 2,594 | 1,783 | 1,783 |
| End Cash Position | 3,709 | 3,326 | 3,502 | 2,594 | 2,597 |
| Net Cash Flow | $1,115 | $732 | $908 | $811 | $814 |
| Free Cash Flow | |||||
| Operating Cash Flow | -979 | -1,362 | -1,186 | -9,026 | -8,262 |
| Free Cash Flow | -979 | -1,362 | -1,186 | -9,026 | -8,262 |